RECRUITING

The Long COVID-19 Wearable Device Study

Talk to us

Conditions

Long COVIDPostural Orthostatic Tachycardia SyndromeDysautonomiaMyalgic EncephalomyelitisChronic Fatigue SyndromeLong Covid19

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

To further characterize Long COVID-19 by collecting data from individuals who already own wearable devices or are provided with a wearable device along with basic and enhanced educational materials to determine if both can improve Long COVID-19 symptom management and post-exertional malaise.

Official Title

The Long COVID-19 Wearable Device Study

Quick Facts

Study Start:2023-11-16
Study Completion:2025-12-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05741112

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Is at least 18 years old.
  2. * Has a self/and or physician diagnosis of:
  3. * Long COVID (based on the WHO working definition),
  4. * ME/CFS (myalgic encephalomyelitis / chronic fatigue syndrome, self-diagnosis based on IOM criteria), and/or
  5. * POTS (Postural Orthostatic Tachycardia Syndrome).
  6. * Is interested in tools to manage ME/CFS, POTS, and/or Long COVID symptoms.
  7. * Owns a wearable device they are willing to use for this study or does not own a device and agrees to utilize a study-provided one.
  8. * Agrees to wear the device throughout the study period, share the data with the study, and sync data at least weekly.
  9. * Has access to a smartphone or tablet to enable syncing wearable data and viewing device feedback.
  10. * Agrees to disclose involvement in other ME/CFS, POTS, and/or Long COVID interventions such as medical treatment, self-management, and other interventional studies.
  11. * Agrees to complete at least 75% of the study surveys.
  1. * As long as they meet inclusion there is no exclusion

Contacts and Locations

Study Contact

Andrea Goosen
CONTACT
0000000000
agoosen@scripps.edu
Romina Foster-Bonds
CONTACT
rfoster@scripps.edu

Study Locations (Sites)

Scripps Research
La Jolla, California, 92037
United States

Collaborators and Investigators

Sponsor: Scripps Translational Science Institute

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-11-16
Study Completion Date2025-12-01

Study Record Updates

Study Start Date2023-11-16
Study Completion Date2025-12-01

Terms related to this study

Additional Relevant MeSH Terms

  • Long COVID
  • Postural Orthostatic Tachycardia Syndrome
  • Dysautonomia
  • Myalgic Encephalomyelitis
  • Chronic Fatigue Syndrome
  • Long Covid19